CA1054935A - Reactif de diagnostic pour le depistage des anticorps viraux - Google Patents

Reactif de diagnostic pour le depistage des anticorps viraux

Info

Publication number: CA1054935A
Authority: CA; Canada
Prior art keywords: gel; diagnostic system; erythrocytes; antibodies; virus
Prior art date: 1974-07-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA231,818A

Other languages

English (en)

Other versions

CA231818S (en

Inventor

Stuart M. Russell

Leonard W.J. Bishop

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Wellcome Foundation Ltd

Original Assignee

Wellcome Foundation Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-07-19

Filing date

1975-07-18

Publication date

1979-05-22

1975-07-18 Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd

1979-05-22 Application granted granted Critical

1979-05-22 Publication of CA1054935A publication Critical patent/CA1054935A/fr

Status Expired legal-status Critical Current

Links

230000003612 virological effect Effects 0.000 title claims description 14
239000003153 chemical reaction reagent Substances 0.000 title abstract description 6
210000003743 erythrocyte Anatomy 0.000 claims abstract description 56
230000000295 complement effect Effects 0.000 claims abstract description 21
230000009089 cytolysis Effects 0.000 claims abstract description 18
239000010839 body fluid Substances 0.000 claims abstract description 16
210000001124 body fluid Anatomy 0.000 claims abstract description 15
241000700605 Viruses Species 0.000 claims description 38
210000002966 serum Anatomy 0.000 claims description 19
239000012530 fluid Substances 0.000 claims description 16
238000000034 method Methods 0.000 claims description 14
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 12
241001465754 Metazoa Species 0.000 claims description 11
210000004369 blood Anatomy 0.000 claims description 10
239000008280 blood Substances 0.000 claims description 10
206010022000 influenza Diseases 0.000 claims description 10
241000712461 unidentified influenza virus Species 0.000 claims description 10
239000000725 suspension Substances 0.000 claims description 8
229920000936 Agarose Polymers 0.000 claims description 7
241000700199 Cavia porcellus Species 0.000 claims description 5
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
241000282555 Erythrocebus patas Species 0.000 claims description 4
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims description 4
241001494479 Pecora Species 0.000 claims description 4
229960001760 dimethyl sulfoxide Drugs 0.000 claims description 4
201000005404 rubella Diseases 0.000 claims description 4
241000712079 Measles morbillivirus Species 0.000 claims description 3
210000001175 cerebrospinal fluid Anatomy 0.000 claims description 3
210000004080 milk Anatomy 0.000 claims description 3
239000008267 milk Substances 0.000 claims description 3
235000013336 milk Nutrition 0.000 claims description 3
238000002156 mixing Methods 0.000 claims description 3
210000002381 plasma Anatomy 0.000 claims description 3
210000003296 saliva Anatomy 0.000 claims description 3
238000005406 washing Methods 0.000 claims description 3
241000283690 Bos taurus Species 0.000 claims description 2
241000701022 Cytomegalovirus Species 0.000 claims description 2
102000004856 Lectins Human genes 0.000 claims description 2
108090001090 Lectins Proteins 0.000 claims description 2
201000005505 Measles Diseases 0.000 claims description 2
241000710799 Rubella virus Species 0.000 claims description 2
239000002158 endotoxin Substances 0.000 claims description 2
239000000417 fungicide Substances 0.000 claims description 2
239000002523 lectin Substances 0.000 claims description 2
239000003755 preservative agent Substances 0.000 claims 2
230000002335 preservative effect Effects 0.000 claims 2
239000003899 bactericide agent Substances 0.000 claims 1
229920006008 lipopolysaccharide Polymers 0.000 claims 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 claims 1
239000002245 particle Substances 0.000 abstract description 11
230000000813 microbial effect Effects 0.000 abstract description 6
230000003993 interaction Effects 0.000 abstract 1
239000000499 gel Substances 0.000 description 49
238000012360 testing method Methods 0.000 description 27
210000004027 cell Anatomy 0.000 description 15
238000002360 preparation method Methods 0.000 description 11
239000000243 solution Substances 0.000 description 8
238000009792 diffusion process Methods 0.000 description 6
230000035931 haemagglutination Effects 0.000 description 6
239000000427 antigen Substances 0.000 description 5
102000036639 antigens Human genes 0.000 description 5
108091007433 antigens Proteins 0.000 description 5
201000010099 disease Diseases 0.000 description 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
244000005700 microbiome Species 0.000 description 5
238000001179 sorption measurement Methods 0.000 description 5
238000010561 standard procedure Methods 0.000 description 5
FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 4
241000196324 Embryophyta Species 0.000 description 4
229960002319 barbital Drugs 0.000 description 4
239000007975 buffered saline Substances 0.000 description 4
229920003023 plastic Polymers 0.000 description 4
MLIWQXBKMZNZNF-KUHOPJCQSA-N (2e)-2,6-bis[(4-azidophenyl)methylidene]-4-methylcyclohexan-1-one Chemical compound O=C1\C(=C\C=2C=CC(=CC=2)N=[N+]=[N-])CC(C)CC1=CC1=CC=C(N=[N+]=[N-])C=C1 MLIWQXBKMZNZNF-KUHOPJCQSA-N 0.000 description 3
206010018910 Haemolysis Diseases 0.000 description 3
206010037151 Psittacosis Diseases 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
239000011521 glass Substances 0.000 description 3
230000008588 hemolysis Effects 0.000 description 3
239000000203 mixture Substances 0.000 description 3
201000000901 ornithosis Diseases 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000894006 Bacteria Species 0.000 description 2
241000287828 Gallus gallus Species 0.000 description 2
241000282414 Homo sapiens Species 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
206010024887 Louping ill Diseases 0.000 description 2
241000204031 Mycoplasma Species 0.000 description 2
102000005348 Neuraminidase Human genes 0.000 description 2
108010006232 Neuraminidase Proteins 0.000 description 2
208000002606 Paramyxoviridae Infections Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
241000251539 Vertebrata <Metazoa> Species 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
230000000694 effects Effects 0.000 description 2
235000013601 eggs Nutrition 0.000 description 2
230000036039 immunity Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
230000010494 opalescence Effects 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
229920001817 Agar Polymers 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
241000588807 Bordetella Species 0.000 description 1
241000588832 Bordetella pertussis Species 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
208000003322 Coinfection Diseases 0.000 description 1
GUBGYTABKSRVRQ-WFVLMXAXSA-N DEAE-cellulose Chemical compound OC1C(O)C(O)C(CO)O[C@H]1O[C@@H]1C(CO)OC(O)C(O)C1O GUBGYTABKSRVRQ-WFVLMXAXSA-N 0.000 description 1
241000709661 Enterovirus Species 0.000 description 1
241000233866 Fungi Species 0.000 description 1
108010010803 Gelatin Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
235000008694 Humulus lupulus Nutrition 0.000 description 1
244000025221 Humulus lupulus Species 0.000 description 1
241001272720 Medialuna californiensis Species 0.000 description 1
208000005647 Mumps Diseases 0.000 description 1
241000204003 Mycoplasmatales Species 0.000 description 1
241000702244 Orthoreovirus Species 0.000 description 1
206010035226 Plasma cell myeloma Diseases 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
241000220010 Rhode Species 0.000 description 1
241000607598 Vibrio Species 0.000 description 1
239000008272 agar Substances 0.000 description 1
150000001299 aldehydes Chemical class 0.000 description 1
230000002391 anti-complement effect Effects 0.000 description 1
108010008730 anticomplement Proteins 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
150000001718 carbodiimides Chemical class 0.000 description 1
239000006285 cell suspension Substances 0.000 description 1
239000013043 chemical agent Substances 0.000 description 1
230000035602 clotting Effects 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
230000000875 corresponding effect Effects 0.000 description 1
230000008021 deposition Effects 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000010828 elution Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
239000008273 gelatin Substances 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
235000011852 gelatine desserts Nutrition 0.000 description 1
125000001475 halogen functional group Chemical group 0.000 description 1
230000002949 hemolytic effect Effects 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
239000003112 inhibitor Substances 0.000 description 1
230000005764 inhibitory process Effects 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000463 material Substances 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
208000010805 mumps infectious disease Diseases 0.000 description 1
201000000050 myeloid neoplasm Diseases 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000011591 potassium Substances 0.000 description 1
238000002203 pretreatment Methods 0.000 description 1
238000000746 purification Methods 0.000 description 1
241000894007 species Species 0.000 description 1
230000002269 spontaneous effect Effects 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000011282 treatment Methods 0.000 description 1
241000701161 unidentified adenovirus Species 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
- G01N33/555—Red blood cell
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
- G01N33/559—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody through a gel, e.g. Ouchterlony technique
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Virology (AREA)
Tropical Medicine & Parasitology (AREA)
Dispersion Chemistry (AREA)
Mycology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA231,818A 1974-07-19 1975-07-18 Reactif de diagnostic pour le depistage des anticorps viraux Expired CA1054935A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB32050/74A GB1501395A (en)	1974-07-19	1974-07-19	Viral anti-body detection

Publications (1)

Publication Number	Publication Date
CA1054935A true CA1054935A (fr)	1979-05-22

Family

ID=10332393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA231,818A Expired CA1054935A (fr)	1974-07-19	1975-07-18	Reactif de diagnostic pour le depistage des anticorps viraux

Country Status (21)

Country	Link
JP (1)	JPS5135418A (fr)
AT (1)	AT352289B (fr)
AU (1)	AU500101B2 (fr)
BE (1)	BE831554A (fr)
BR (1)	BR7504584A (fr)
CA (1)	CA1054935A (fr)
CH (1)	CH621874A5 (fr)
DE (1)	DE2532283A1 (fr)
DK (1)	DK328075A (fr)
ES (1)	ES439520A1 (fr)
FI (1)	FI752081A7 (fr)
FR (1)	FR2278308A1 (fr)
GB (1)	GB1501395A (fr)
IE (1)	IE41633B1 (fr)
IL (1)	IL47736A (fr)
IT (1)	IT1048304B (fr)
NL (1)	NL7508624A (fr)
NO (1)	NO752568L (fr)
NZ (1)	NZ178160A (fr)
SE (1)	SE7508228L (fr)
ZA (1)	ZA754643B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1146852A (fr) *	1979-01-31	1983-05-24	Koichi Kondo	Reactif d'agglutination du latex

1974
- 1974-07-19 GB GB32050/74A patent/GB1501395A/en not_active Expired
1975
- 1975-07-17 ES ES439520A patent/ES439520A1/es not_active Expired
- 1975-07-18 NZ NZ178160A patent/NZ178160A/xx unknown
- 1975-07-18 SE SE7508228A patent/SE7508228L/ not_active Application Discontinuation
- 1975-07-18 NL NL7508624A patent/NL7508624A/xx not_active Application Discontinuation
- 1975-07-18 NO NO752568A patent/NO752568L/no unknown
- 1975-07-18 ZA ZA754643A patent/ZA754643B/xx unknown
- 1975-07-18 BE BE158461A patent/BE831554A/fr unknown
- 1975-07-18 CH CH944975A patent/CH621874A5/de not_active IP Right Cessation
- 1975-07-18 DK DK328075A patent/DK328075A/da unknown
- 1975-07-18 IT IT50589/75A patent/IT1048304B/it active
- 1975-07-18 AT AT558875A patent/AT352289B/de not_active IP Right Cessation
- 1975-07-18 CA CA231,818A patent/CA1054935A/fr not_active Expired
- 1975-07-18 FI FI752081A patent/FI752081A7/fi not_active Application Discontinuation
- 1975-07-18 FR FR7522492A patent/FR2278308A1/fr active Granted
- 1975-07-18 IE IE1605/75A patent/IE41633B1/en unknown
- 1975-07-18 AU AU83175/75A patent/AU500101B2/en not_active Expired
- 1975-07-18 BR BR7504584*A patent/BR7504584A/pt unknown
- 1975-07-18 IL IL47736A patent/IL47736A/xx unknown
- 1975-07-18 JP JP50088187A patent/JPS5135418A/ja active Pending
- 1975-07-18 DE DE19752532283 patent/DE2532283A1/de not_active Withdrawn

Also Published As

Publication number	Publication date
IT1048304B (it)	1980-11-20
AT352289B (de)	1979-09-10
FR2278308B1 (fr)	1979-03-09
NL7508624A (nl)	1976-01-21
IL47736A0 (en)	1975-10-15
IL47736A (en)	1978-07-31
IE41633L (en)	1976-01-19
AU500101B2 (en)	1979-05-10
GB1501395A (en)	1978-02-15
DK328075A (da)	1976-01-20
DE2532283A1 (de)	1976-01-29
SE7508228L (sv)	1976-01-20
JPS5135418A (fr)	1976-03-25
IE41633B1 (en)	1980-02-13
FR2278308A1 (fr)	1976-02-13
ES439520A1 (es)	1977-04-01
CH621874A5 (en)	1981-02-27
ATA558875A (de)	1979-02-15
AU8317575A (en)	1977-01-20
ZA754643B (en)	1977-02-23
NO752568L (fr)	1976-01-20
BE831554A (fr)	1976-01-19
BR7504584A (pt)	1976-07-06
NZ178160A (en)	1978-06-20
FI752081A7 (fr)	1976-01-20

Publication	Publication Date	Title
CA1149277A (fr)	1983-07-05	Methode de dosage des complexes immuns
US4608246A (en)	1986-08-26	Testing for a blood group immunological reaction
US5312744A (en)	1994-05-17	Method of immobilizing and preserving an immunologically reactive substance
US4474878A (en)	1984-10-02	Sandwich EIA for antigen associated with hepatitis
US5004699A (en)	1991-04-02	Method to detect fungi and yeasts
JPH0779694B2 (ja)	1995-08-30	蛋白質および同類品の保護
US4157280A (en)	1979-06-05	Test set for detecting the presence of antigens associated with hepatitis
US4403037A (en)	1983-09-06	Erythrocyte preparations and use thereof in hemagglutination tests
Berg et al.	1986	Mitochondrial antigens and autoantibodies: from anti-M1 to anti-M9
US4176174A (en)	1979-11-27	Viral antibody diagnostic test system
FI68468B (fi)	1985-05-31	Direkt agglutineringstest foer paovisning av antigener i kroppsvaetskor
US4729961A (en)	1988-03-08	Process for the detection and assay by erythroadsorption
Perry et al.	1996	Autoreactive T cell specificity in autoimmune hemolytic anemia of the NZB mouse
US5552288A (en)	1996-09-03	Chromogen agar color reactive test sheet
CA1054935A (fr)	1979-05-22	Reactif de diagnostic pour le depistage des anticorps viraux
Winter et al.	1959	Rapid Identification of Pasteurella Pestis with Fluorescent Antibody: II. Specific Identification of Pasteurella Pestis in Dried Smears
Smink et al.	1967	Immunologic demonstration of a deficiency of Hageman factor-like material in Hageman trait
EP0091911A4 (fr)	1984-04-06	Detection immunohistochimique a l'oxydase de glucose d'anticorps anti-nucleaires.
Honigberg et al.	1968	Immunologic analysis by quantitative fluorescent antibody methods of the effects of prolonged cultivation on Trichomonas gallinae
Tauraso et al.	1971	Effect of various methods of removing non-specific inhibitors to virus hemagglutination upon serum proteins and immunoglobulins
Parr et al.	1973	Paraformaldehyde Fixation of Mouse Cells with Preservation of Antibody‐Binding by the H‐2 Locus
CA2035646A1 (fr)	1991-10-13	Dosage immunologique de chlamydia au moyen de la methode demi-sandwich
JPH05142122A (ja)	1993-06-08	固相細胞の乾燥固定方法
Sirchia et al.	1971	Normal human lymphocytes treated in vitro with the sulfhydryl compound AET: relationship to the lymphocytes of paroxysmal nocturnal hemoglobinuria
CA1163926A (fr)	1984-03-20	Preservation des cultures monocouches de tissus cellulaires a l'aide d'une cire insoluble